Bloomberg Law
April 26, 2021, 1:56 PM

Neuriva Brain Booster $8 Million False Ad Deal Gets Early Nod

Julie Steinberg
Julie Steinberg

An $8 million false ad class settlement between Neuriva memory supplement consumers and Reckitt Benckiser LLC and RB Health (US) LLC won a Florida federal court’s tentative approval.

David Williams and others alleged the companies deceptively touted the brain booster as “backed by science” and “clinically proven” to improve brain performance when there is no scientific or clinical proof that Neuriva provides any benefit to the brain.

The nationwide deal covers individuals who bought Neuriva products after Jan. 1, 2019, for personal use. Class members with proof of purchase are eligible to recover up to $65. Those without proof may ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.